PNB Vesper: Betting Big On Research

Kochi-based PNB Vesper’s semi-virtual web of researchers, universities, and CROs across continents has some promising leads in the pre-clinical pipeline. Promoter PN Balaram says this cost-effective research model is the way forward to achieve India’s drug research goals

- 

Most promoters of phar-maceutical companiesin India have traditionally focussed more on manufacturing generic drugs. But a Kochi-based entrepreneur decided to harness the research of scientists from across the world, and create a business model that thrives on R&D. PNB Vesper is ‘a semi-virtual’ mode, with most of its preclinical research and development activities being conducted by academic and commercial organisations in the UK, the US, Thailand and India. Though the business is in its early days, it’s interesting to note its developments and growth vision.

PN Balaram, Managing Director of the company started his entrepreneurial journey when he was 20 years in a collaboration with Japan’s Toshiba to manufacture televisions. While he established his business in the electronics and DTH satellite marketing sector, he also established businesses in the distilleries and foods sector. He then ventured into the research domain with the launch of Cybele Herbal Laboratories.

So what motivated Balaram to venture into the researchdriven pharma industry, especially with no background in this domain? Balaram says, “I cannot give a definite answer for this question. Circumstances led me to conduct drug research. Maybe the almighty assigned this task to me. One thing is for sure, if we are successful in our research, the society will be majorly benefited.”

The journey so far

As American writer Irving Stone says, “To become a master at any skill, it takes the total effort of your heart, mind, and soul working together in tandem.”

So, how did it all start for PNB Vesper?